These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 101472)

  • 1. Three anorectic drugs: similar structures but different effects on brain and behavior.
    Hoebel BG
    Int J Obes; 1978; 2(2):157-66. PubMed ID: 101472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of anorectic drug effects on food intake, self-stimulation, and stimulation-escape.
    Kornblith CL; Hoebel BG
    Pharmacol Biochem Behav; 1976 Aug; 5(2):215-8. PubMed ID: 996053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative action of fenfluramine and amphetamine in rats with hypothalamic obesity].
    Bernier A; Sicot N; Le Douarec JC
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):762-72. PubMed ID: 4904574
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rôle of anorectic agents and other drugs in treatment of obesity].
    Laurent LP
    Vie Med Can Fr; 1972 May; 1(5):491-3. PubMed ID: 4643642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorectic drugs: use in general practice.
    Craddock D
    Drugs; 1976; 11(5):378-93. PubMed ID: 782835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain neurotransmitters in food and drug reward.
    Hoebel BG
    Am J Clin Nutr; 1985 Nov; 42(5 Suppl):1133-50. PubMed ID: 2865893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of obesity.
    Sullivan AC; Comai K
    Int J Obes; 1978; 2(2):167-89. PubMed ID: 30732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
    Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.
    Kim ER; Leckstrom A; Mizuno TM
    Behav Brain Res; 2008 Dec; 194(1):66-71. PubMed ID: 18639588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.